Klazina Kooiman received the M.Sc. degree with honors (cum laude) in biopharmaceutical sciences specializing in pharmaceutical technology from Leiden University, Leiden, the Netherlands, and the Ph.D. degree in ultrasound contrast agents for therapy from the Department of Biomedical Engineering, Thoraxcenter, Erasmus MC University Medical Center Rotterdam, the Netherlands, in 2011. Dr. Kooiman was a recipient of the EFUSMB 2011 Young Investigator Award, Vienna, Austria. In 2018, she acquired the prestigious ERC starting grant from the European Research Council, and in 2019 the prestigious Vidi Grant from the Netherlands Organization for Scientific Research, domain Applied and Engineering Sciences. She is currently an Associate Professor and the Head of the Therapeutic Ultrasound Contrast Agent Group, Department of Biomedical Engineering, Thoraxcenter, Erasmus MC University Medical Center Rotterdam, focusing on using ultrasound contrast agents for drug delivery and molecular imaging. She is the co-director of the Annual European Symposium on Ultrasound Contrast Imaging, Rotterdam, which is attended by approximately 180 scientists from universities and industries all over the world.